×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TLSA – tiziana life sciences ltd - common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TLSA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/19
07:06 am
tlsa
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association [Yahoo! Finance]
Medium
Report
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association [Yahoo! Finance]
11/19
07:00 am
tlsa
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
Medium
Report
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
11/1
01:00 pm
tlsa
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
Low
Report
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
10/30
10:36 pm
tlsa
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million [Yahoo! Finance]
High
Report
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million [Yahoo! Finance]
10/30
10:29 pm
tlsa
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
High
Report
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
10/30
08:30 am
tlsa
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
Medium
Report
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
10/20
07:30 am
tlsa
Tiziana Life Sciences Advances with Promising Drug Trials [Yahoo! Finance]
Low
Report
Tiziana Life Sciences Advances with Promising Drug Trials [Yahoo! Finance]
9/19
07:00 am
tlsa
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
Medium
Report
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/19
07:01 am
tlsa
Form 6-K Tiziana Life Sciences For: Nov 19
Medium
Report
Form 6-K Tiziana Life Sciences For: Nov 19
11/1
01:08 pm
tlsa
Form 6-K Tiziana Life Sciences For: Nov 01
Low
Report
Form 6-K Tiziana Life Sciences For: Nov 01
11/1
06:12 am
tlsa
Form 424B5 Tiziana Life Sciences
Medium
Report
Form 424B5 Tiziana Life Sciences
11/1
06:03 am
tlsa
Form 6-K Tiziana Life Sciences For: Oct 31
Medium
Report
Form 6-K Tiziana Life Sciences For: Oct 31
10/30
08:31 am
tlsa
Form 6-K Tiziana Life Sciences For: Oct 30
Medium
Report
Form 6-K Tiziana Life Sciences For: Oct 30
10/25
05:15 pm
tlsa
Form 6-K Tiziana Life Sciences For: Oct 25
Low
Report
Form 6-K Tiziana Life Sciences For: Oct 25
10/25
05:01 pm
tlsa
Form 424B5 Tiziana Life Sciences
Low
Report
Form 424B5 Tiziana Life Sciences
10/18
05:00 pm
tlsa
Form 6-K Tiziana Life Sciences For: Oct 18
Medium
Report
Form 6-K Tiziana Life Sciences For: Oct 18
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/9
Tiziana Lifesciences Develops Novel Investigational Treatment For Patients Infected with COVID-19 Utilizing Direct Delivery of Anti-Interlukin-6-Receptor Monoclonal Antibodies
56.7%
3/11 Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $10 Million 28.3%
6/3 Form 6-K Tiziana Life Sciences For: Jun 03 21.4%
3/13 Form 6-K Tiziana Life Sciences For: Mar 13 9.5%
7/1 Form 6-K Tiziana Life Sciences For: Jul 01 9.2%
7/22 Form 6-K Tiziana Life Sciences For: Jul 22 9.0%
9/4 Form 6-K Tiziana Life Sciences For: Sep 04 8.6%
4/24 Tiziana Life Sciences Acquires a Nanoparticle-Based Formulation Technology for Controlled Delivery of Actinomycin D for Treatment of Myelodysplastic syndrome and Acute Myeloid Leukemia 5.7%
3/20 Tiziana Life Sciences PLC (NASDAQ: TLSA) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 4.1%
5/28 Tiziana Life Sciences to Present at the 9th Annual LD Micro Invitational 2.7%
3/11 Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $10 Million 28.3%
6/3 Form 6-K Tiziana Life Sciences For: Jun 03 21.4%
3/13 Form 6-K Tiziana Life Sciences For: Mar 13 9.5%
7/1 Form 6-K Tiziana Life Sciences For: Jul 01 9.2%
7/22 Form 6-K Tiziana Life Sciences For: Jul 22 9.0%
9/4 Form 6-K Tiziana Life Sciences For: Sep 04 8.6%
4/24 Tiziana Life Sciences Acquires a Nanoparticle-Based Formulation Technology for Controlled Delivery of Actinomycin D for Treatment of Myelodysplastic syndrome and Acute Myeloid Leukemia 5.7%
3/20 Tiziana Life Sciences PLC (NASDAQ: TLSA) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 4.1%
5/28 Tiziana Life Sciences to Present at the 9th Annual LD Micro Invitational 2.7%
TOP News Decliners
1/9
Form 6-K Tiziana Life Sciences For: Jan 09
-39.2%
4/9 Form 6-K Tiziana Life Sciences For: Apr 09 -25.3%
4/15 Form 6-K Tiziana Life Sciences For: Apr 15 -14.9%
2/14 Form FWP Tiziana Life Sciences Filed by: Tiziana Life Sciences plc -12.1%
8/5 Form F-1 Tiziana Life Sciences -10.6%
4/1 Form 6-K Tiziana Life Sciences For: Apr 01 -10.0%
4/14 Form 6-K Tiziana Life Sciences For: Apr 14 -9.9%
10/30 Form 6-K Tiziana Life Sciences For: Oct 30 -8.2%
4/27 Tiziana Life Sciences Files Patent on Combination of Nanoparticle-Actinomycin D with Anti-Interleukin-6 Receptor Monoclonal Antibody for Treatment of Coronaviruses -7.9%
11/19 Tiziana Life Sciences PLC (NASDAQ: TLSA) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -7.1%
4/9 Form 6-K Tiziana Life Sciences For: Apr 09 -25.3%
4/15 Form 6-K Tiziana Life Sciences For: Apr 15 -14.9%
2/14 Form FWP Tiziana Life Sciences Filed by: Tiziana Life Sciences plc -12.1%
8/5 Form F-1 Tiziana Life Sciences -10.6%
4/1 Form 6-K Tiziana Life Sciences For: Apr 01 -10.0%
4/14 Form 6-K Tiziana Life Sciences For: Apr 14 -9.9%
10/30 Form 6-K Tiziana Life Sciences For: Oct 30 -8.2%
4/27 Tiziana Life Sciences Files Patent on Combination of Nanoparticle-Actinomycin D with Anti-Interleukin-6 Receptor Monoclonal Antibody for Treatment of Coronaviruses -7.9%
11/19 Tiziana Life Sciences PLC (NASDAQ: TLSA) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -7.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: